Reuters -
22 January 2018, 15:53 (+ 2303 days 16 hours and 19 minutes) Health
(Reuters) - Celgene Corp announced a $9 billion cash buyout of Juno Therapeutics Inc on Monday as it moves to cement its position as a key player in a new range of cancer therapies.